PPG Highlights 2022 Performance During Annual Meeting

2023-04-21
财报
PPG held its annual meeting of shareholders, where Tim Knavish, PPG president and CEO, highlighted the company’s performance in 2022. “We achieved record full-year net sales of approximately $17.7 billion, up 5% compared with 2021, led by an 8% increase in organic sales driven by higher selling prices,” Knavish said. “We exited the year with a strong balance sheet that will provide continued financial flexibility as we execute our growth strategy. “The success of our team’s work throughout the year has enabled us to continue to reward our shareholders,” Knavish added. “In 2022, we raised our annual dividend for the 51st consecutive year and achieved our 123rd year of uninterrupted annual dividends, which places PPG in a select group of companies that have achieved these significant milestones.” Knavish also highlighted several key environmental, social and governance (ESG) actions and achievements in 2022, including: • Reducing greenhouse gas emissions by 13%, lowering total energy use by 8%, and decreasing waste disposal intensity by 16% from the 2017 baseline. • Submitting greenhouse gas (GHG) emissions reduction targets to the Science-Based Target initiative for validation. • Investing $16.2 million globally to support nonprofits, including more than $9 million to advance education in science, technology, engineering and math (STEM). PPG will publish its latest all-digital ESG report in May. Looking ahead, Knavish said: “As the economic environment improves, we anticipate having increased opportunities to create additional value for our shareholders, customers and employees. I’m confident that our team will deliver by focusing on cash generation, margin management and earnings growth.” At the meeting, shareholders re-elected directors Stephen F. Angel, chairman of the board of Linde plc; Hugh Grant, retired chairman of the board and CEO of Monsanto Company; Melanie L. Healey, former group president North America of the Procter & Gamble Company; and Guillermo Novo, chairman and CEO or Ashland Inc., in addition to Knavish.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。